The previously mentioned observation on altered BDNF expression is particularly salient in the context of the development of obesity as a complication of antipsychotic treatment, as research has demonstrated a correlation between BMI increase and a gradual decline in BDNF levels as obesity progresses. The gene discussed is BDNF; the disease is obesity due to melanocortin 4 receptor deficiency.